Page last updated: 2024-10-28

lidocaine and Amyloidosis

lidocaine has been researched along with Amyloidosis in 1 studies

Lidocaine: A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE.
lidocaine : The monocarboxylic acid amide resulting from the formal condensation of N,N-diethylglycine with 2,6-dimethylaniline.

Amyloidosis: A group of sporadic, familial and/or inherited, degenerative, and infectious disease processes, linked by the common theme of abnormal protein folding and deposition of AMYLOID. As the amyloid deposits enlarge they displace normal tissue structures, causing disruption of function. Various signs and symptoms depend on the location and size of the deposits.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Khandji, J1
Shah, P1
Charles, N1
Patel, P1

Other Studies

1 other study available for lidocaine and Amyloidosis

ArticleYear
Recurrent profuse hemorrhage after chalazion excision in a patient with systemic amyloidosis.
    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 2017, Volume: 52, Issue:4

    Topics: Amyloidosis; Anesthetics, Local; Chalazion; Epinephrine; Female; Fibrin Tissue Adhesive; Hemostatic

2017